Probiotics 연구의 방향성과 신개념 Probiotics
(주)코리아스칼라
- 최초 등록일
- 2023.06.19
- 최종 저작일
- 2020.06
- 8페이지/ 어도비 PDF
- 가격 4,000원
* 본 문서는 배포용으로 복사 및 편집이 불가합니다.
서지정보
ㆍ발행기관 : 한국유산균학회
ㆍ수록지정보 : Current Topic in Lactic Acid Bacteria and Probiotics / 6권 / 1호
ㆍ저자명 : 김재원
목차
Abstract
서 론
본론
Probiotics의 정의 및 현황
Prebiotics의 정의 및 현황
Synbiotics(Symbiotics)의 정의 및 현황
NGP 및 Next-Generation Prebiotics(NGPre) 현황
Pharmabiotics의 정의 및 현황
Pharmabiotics의 상품화
결 론
References
영어 초록
The association of lactic acid bacteria in human health has been investigated from early 1900s. The term of probiotics was defined in 1953 and various strains (Lactobacillus, Bifidobacterium, Streptococcus etc) have been isolating with diverse beneficial effects on human health. Over the century, the concept of traditional probiotics was based on observation of natural properties to restore healthy condition within different human ecosystems (intestine, skin etc) following by development of processing optimization for the stability of bacteria. Nowadays, the aim of probiotics for human health has been moving from gut stabilization towards expanded concept of pharmabiotics like as controlling disease (e.g. obesity, immune system, psychiatric stabilization etc). Along with the expansion, scientists and industry still remained to investigate reliability of efficacy by consumption of probiotics. In recent, probiotics and bacteriophage cocktails have been commercialized in the US market. The cocktails consist of several probiotic strains with four phages targeting pathogenic E. coli. The phages induce reduction of population in E.coli and Clostridium perfringens while prevalence of Eubacterium increased in a gut to 4–5 times prior to consumption. Also, immunological stabilization was observed by consumption ‘probiotics with phage’. Now, the probiotic R&D is moving towards pharmabiotics, and additional technologies in next-generation probiotics and prebiotics are actively investigating worldwide.
참고 자료
없음
"Current Topic in Lactic Acid Bacteria and Probiotics"의 다른 논문